Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 2
2005 3
2006 4
2007 4
2008 3
2009 2
2010 1
2012 2
2013 8
2014 9
2015 1
2016 17
2017 10
2018 11
2019 8
2020 13
2021 20
2022 24
2023 20
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Results by year

Filters applied: . Clear all
Page 1
Antipsychotics and risk of QT prolongation: a pharmacovigilance study.
Bordet C, Garcia P, Salvo F, Touafchia A, Galinier M, Sommet A, Montastruc F. Bordet C, et al. Among authors: salvo f. Psychopharmacology (Berl). 2023 Jan;240(1):199-202. doi: 10.1007/s00213-022-06293-4. Epub 2022 Dec 14. Psychopharmacology (Berl). 2023. PMID: 36515735
Quelle place pour l’automatisation intelligente et l’intelligence artificielle pour préserver et renforcer l’expertise en vigilance devant l’augmentation des déclarations ?
Pariente A, Micallef J, Lahouegue A, Molimard M, Auffret M, Chouchana L, Denis B, Faillie JL, Grandvuillemin A, Letinier L, Pierron E, Pons C, Pujade I, Rubino H, Salvo F. Pariente A, et al. Among authors: salvo f. Therapie. 2023 Jan-Feb;78(1):115-129. doi: 10.1016/j.therap.2022.11.003. Epub 2022 Nov 25. Therapie. 2023. PMID: 36577617 French. No abstract available.
Will the future of pharmacovigilance be more automated?
Salvo F, Micallef J, Lahouegue A, Chouchana L, Létinier L, Faillie JL, Pariente A. Salvo F, et al. Expert Opin Drug Saf. 2023 Jul-Dec;22(7):541-548. doi: 10.1080/14740338.2023.2227091. Epub 2023 Jul 12. Expert Opin Drug Saf. 2023. PMID: 37435796 Review.
Interpretation of Pharmacovigilance Disproportionality Analyses.
Khouri C, Fusaroli M, Salvo F, Raschi E. Khouri C, et al. Among authors: salvo f. Clin Pharmacol Ther. 2023 Oct;114(4):745-746. doi: 10.1002/cpt.2951. Epub 2023 May 30. Clin Pharmacol Ther. 2023. PMID: 37248829 No abstract available.
Transparency and robustness of safety signals.
Khouri C, Fusaroli M, Salvo F, Raschi E. Khouri C, et al. Among authors: salvo f. BMJ. 2022 Nov 3;379:o2588. doi: 10.1136/bmj.o2588. BMJ. 2022. PMID: 36328354 No abstract available.
Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis.
Raschi E, Salvo F, Bate A, De Ponti F, Poluzzi E, Tuccori M, van Puijenbroek E, Joshi N, Khouri C. Raschi E, et al. Among authors: salvo f. Drug Saf. 2024 Mar 18. doi: 10.1007/s40264-024-01419-3. Online ahead of print. Drug Saf. 2024. PMID: 38498258 No abstract available.
Medicine misuse: A systematic review and proposed hierarchical terminology.
Singier A, Noize P, Berdaï D, Daveluy A, Arnaud M, Molimard M, Bégaud B, Salvo F. Singier A, et al. Among authors: salvo f. Br J Clin Pharmacol. 2021 Apr;87(4):1695-1704. doi: 10.1111/bcp.14604. Epub 2020 Dec 8. Br J Clin Pharmacol. 2021. PMID: 33295072 Free article. Review.
141 results